Sun Pharma Advanced Research Company dropped 1.91% to Rs 156.8 at 11:54 IST on the BSE after the company reported a net loss of Rs 94.19 crore in Q1 June 2019 as compared with a net loss of Rs 64.48 crore in Q1 June 2018.
The result was announced after market hours yesterday, 29 July 2019.
Meanwhile, the S&P BSE Sensex was up by 28.02 points or 0.07% to 37,714.39.
On the BSE, 1.47 lakh shares were traded in the counter so far compared with average daily volumes of 3.07 lakh shares in the past two weeks. The stock had hit a high of Rs 163.9 and a low of Rs 152 so far during the day. The stock hit a 52-week high of Rs 413.4 on 31 August 2018 and hit a 52-week low of Rs 107 on 9 June 2019.
The company's net sales increased 3% to Rs 17.32 crore in Q1 June 2019 over Q1 June 2018.
Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The company works on innovation and new product development for global markets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app